Chemical constituents from Syringa reticulata (Bl.) Hara

Comparative Component Composition of Flowers in Several Syringa Species (Oleaceae)

Because insufficient relevant data are available, the component composition of flowers was studied comparatively in six lilac species of the genus Syringa L. (Oleaceae): S. emodi Wall., S. josikaea Jacg., S. komarowii Schneid., S. reticulata (Blume) H. Hara ssp. amurensis (Rupr.) P. S. Green et M. C. Chang, S. sweginzowii Koehne et Lingelsh, and S. vulgaris L. Plants were from the collection of the South Ural Botanical Garden-Institute. Contents were established for major groups of biologically active substances (BASs): flavonoids, hydroxycinnamic acids, tannins, and organic acids. The highest contents of all BAS groups were observed in S. komarowii flowers: flavonoids, 4.25 ± 0.21%; hydroxycinnamic acids, 6.13 ± 0.29%; tannins, 9.3 ± 0.5%; ascorbic acid, 0.468 ± 0.022%; and organic acids, 10.7 ± 0.5%. The contents were somewhat lower in S. emodi and S. sweginzowii and minimum in S. josikaea. Comparisons of the qualitative and quantitative BAS profiles showed that certain Syringa species cultivated in the Republic of Bashkortostan are promising to further study in terms of their possible use in scientific medicine and the development of herbal remedies.

Six new Secoiridoid glycosides from the stem barks of Syringa Reticulata (Bl.) Hara

Six new secoiridoids, syrretosides E-J (1-6) and four known secoiridoids (7-10), were isolated from the stem barks of Syringa reticulata. Their structures were established by the 1D and 2D NMR spectra, HR-ESI-MS, and comparison with the literature. The cytotoxicity of the isolated monomeric compounds against RAW264.7 cells was investigated by the CCK8 assay, and the results showed that the individual compounds were not cytotoxic to RAW264.7. The anti-inflammatory activity of these compounds was evaluated using the LPS-induced RAW264.7 inflammatory cell model and the results showed that compounds 3-7 and 9 showed varying degrees of anti-inflammatory activity.

Four new secoiridoids from the stem barks of Syringa reticulata (Bl.) Hara

Four new secoiridoids, syrretoside A (1), syrretoside B (2), 5β, 8β-syrretaglucone C(3), 5β, 8α-syrretaglucone C (4), together with eight known secoiridoids (5-12), were isolated from the stem barks of Syringa reticulata (Bl.) Hara. The structures of isolated compounds were established based on the physical and chemical means, NMR spectroscopy, high-resolution mass spectrometry (HR-ESI-MS), and circular dichroism spectrum (CD), as well as in comparison with the literature. The cytotoxicity of isolated compounds was investigated using CCK8 assay, which showed that these compounds had different degrees of inhibitory effect on two human tumor (MGC803, LN229) cell lines.

Traditional uses, phytochemistry and pharmacology of genus Syringa: A comprehensive review

ETHNOPHARMACOLOGICAL RELEVANCE

Genus Syringa, which belongs to Oleaceae family, contains 21 accepted species mainly distributed in Southeast Europe, Japan, China, Himalayas, etc. The various parts of Syringa species have been used as traditional Chinese herbal medicines for treatment of cough, myocardial ischemia, acute icteric hepatitis, diarrhea, conjunctivitis, bronchitis and other ailments.

AIM OF THE STUDY

A more comprehensive and in-depth review about the phytochemistry, pharmacology, traditional medicinal uses and clinical applications as well as toxicology of Syringa have summarized and hope to provide a relatively novel angle for further clinical applicantion on genus.

MATERIALS AND METHODS

The literatures about Syringa were collected via a series of scientific search engines including Web of Science, PubMed, Elsevier, Google Scholar, SciFinder and CNKI.

RESULTS

The phytochemical studies revealed that about 302 compounds include phenylpropanoids, iridoids, phenylethanols, flavonoids, triterpenes and other minor compounds have been isolated and identified from Syringa species. Phenylpropanoids and iridoids are the main constituents among these compounds and may be responsible for the activities directly or indirectly. As traditional medicine, Syringa applied to treat cough, diarrhea, acute icteric hepatitis, vomit, abdominal pain, bronchitis and other ailments. Most of traditional uses are related the biological activities and confirmed by modern studies. Pharmacological researches in vitro and in vivo revealed that the extracts and pure compounds possessed significantly hepatoprotective, anti-inflammatory, antimicrobial, antioxidant, antitumor, antiviral, cardioprotective, immunomodulatory and other activities.

CONCLUSIONS

The phytochemistry, pharmacology, traditional uses and clinical applications described in this article demonstrated that Syringa species possessed a huge number of activities and these findings will promote the further action mechanisms studies. However, fewer preclinical and clinical studies are focued on the pharmacokinetics of crudes extracts and conpounds from Syringa. The explored of new agents with Syringa species as ingredients may be limited. It points to the further in-depth investigations on pharmacokinetics as well as toxicological are essential in future for assessment the effectiveness and safety of drug.